.jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies.., and bones, and it�s not clear how the drugs will affect them after long-term use..sign out..
"as soon as she saw him," said tamara nunley, r.n., "you could see her perk up.".